| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-11 17:29:59 UTC |
|---|
| Update Date | 2022-07-15 00:38:55 UTC |
|---|
| HMDB ID | HMDB0029365 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | N-trans-feruloyltyramine |
|---|
| Description | N-trans-feruloyltyramine (NFT), also known as Moupinamide or Alfrutamide or N-feruloyltyramine or trans-N-Feruloyltyramine, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. It is also classified as a phenylpropanoid amide. Phenylpropanoids consist of a six-carbon, aromatic phenyl group and a three-carbon propene tail of coumaric acid, which is the central intermediate in phenylpropanoid biosynthesis. A phenylpropanoid amide has an amide group incorporated into its propanoid chain. There are two known isomers of N-Feruloyltyramine, N-trans-Feruloyltyramine and N-cis-Feruloyltyramine. N-trans-feruloyltyramine (Moupinamide) is a largely neutral molecule, that is somewhat insoluble in water. It exists as a white crystalline solid. Moupinamide or N-trans-Feruloyltyramine is one of the major phenylpropanoid amides that have been identified in the cannabis plant (PMID:6991645 ). It is also found in black and white peppers, the leaves of the Chinese pepper tree as well as eggplant (PMID: 34335243 ). This could make moupinamide a potential biomarker for the consumption of these plants/foods. Moupinamide is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases, they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. N-trans-feruloyltyramine or NFT has a number of potential therapeutic or beneficial effects in humans. It is an inhibitor of COX 1 and COX 2 and has potential antioxidant properties (PMID: 19807156 ). More recently, trans-N-Caffeoyltyramine has been identified to by a potent HNF4α agonist (PMID: 35087037 ). HNF4A or HNF4α is also known as Hepatocyte nuclear factor 4 alpha. It is also known as NR2A1 (nuclear receptor subfamily 2, group A, member 1 and) is a nuclear receptor that in humans is encoded by the HNF4A gene. Moupinamide (NFT) has been found to promote weight loss by inducing an increase in mitochondrial mass and function, including fatty acid oxidation. It also promotes the reversal of hepatic steatosis through a mechanism involving the stimulation of lipophagy by dihydroceramides (PMID: 34117215 ). This has made Moupinamide or NFT a strong candidate as a NAFLD (non-alcoholic fatty liver disease) therapeutic. |
|---|
| Structure | COC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O InChI=1S/C18H19NO4/c1-23-17-12-14(4-8-16(17)21)5-9-18(22)19-11-10-13-2-6-15(20)7-3-13/h2-9,12,20-21H,10-11H2,1H3,(H,19,22)/b9-5+ |
|---|
| Synonyms | | Value | Source |
|---|
| N-[(e)-Feruloyl]tyramine | ChEBI | | trans-N-Feruloyltyramine | ChEBI | | Feruloyltyramine, (Z)-isomer | MeSH | | N-Feruloyltyramine | MeSH | | Feruloyltyramine | MeSH | | Feruloyltyramine, (e)-isomer | MeSH | | (2,3)trans-N-(P-Hydroxyphenethyl)ferulamide | HMDB | | N-trans-Feruloyltyramine | HMDB | | Moupinamide | ChEBI | | (2E)-3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidate | HMDB | | (2,3) trans-N-(P-Hydroxyphenethyl)ferulamide | HMDB | | (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-2-propenamide | HMDB | | (2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide | HMDB | | NFT | HMDB | | Alfrutamide | HMDB | | 3-(4-hydroxy-3-methoxyphenyl)-N-(2-(4-hydroxyphenyl)ethyl)-2-Propenamide | HMDB |
|
|---|
| Chemical Formula | C18H19NO4 |
|---|
| Average Molecular Weight | 313.3478 |
|---|
| Monoisotopic Molecular Weight | 313.131408101 |
|---|
| IUPAC Name | (Z,2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid |
|---|
| Traditional Name | (Z,2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid |
|---|
| CAS Registry Number | 66648-43-9 |
|---|
| SMILES | COC1=CC(\C=C\C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O |
|---|
| InChI Identifier | InChI=1S/C18H19NO4/c1-23-17-12-14(4-8-16(17)21)5-9-18(22)19-11-10-13-2-6-15(20)7-3-13/h2-9,12,20-21H,10-11H2,1H3,(H,19,22)/b9-5+ |
|---|
| InChI Key | NPNNKDMSXVRADT-WEVVVXLNSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenols |
|---|
| Sub Class | Methoxyphenols |
|---|
| Direct Parent | Methoxyphenols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Methoxyphenol
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- Styrene
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Monocyclic benzene moiety
- Carboximidic acid
- Carboximidic acid derivative
- Ether
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Organic nitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 144.5 - 145 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 382.8 mg/L @ 25 °C (est) | The Good Scents Company Information System | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.11 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 11.5471 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.62 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1837.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 230.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 162.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 161.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 142.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 540.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 402.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 127.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1068.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 437.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1226.3 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 303.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 351.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 286.2 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 227.9 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 20.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Moupinamide,1TMS,isomer #1 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O | 3250.6 | Semi standard non polar | 33892256 | | Moupinamide,1TMS,isomer #2 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C | 3286.1 | Semi standard non polar | 33892256 | | Moupinamide,1TMS,isomer #3 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C)=CC=C1O | 3255.3 | Semi standard non polar | 33892256 | | Moupinamide,2TMS,isomer #1 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C)C=C2)=CC=C1O[Si](C)(C)C | 3316.2 | Semi standard non polar | 33892256 | | Moupinamide,2TMS,isomer #2 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O | 3177.3 | Semi standard non polar | 33892256 | | Moupinamide,2TMS,isomer #3 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3244.2 | Semi standard non polar | 33892256 | | Moupinamide,3TMS,isomer #1 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 3225.4 | Semi standard non polar | 33892256 | | Moupinamide,3TMS,isomer #1 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C)C=C2)[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 2960.5 | Standard non polar | 33892256 | | Moupinamide,1TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O | 3543.7 | Semi standard non polar | 33892256 | | Moupinamide,1TBDMS,isomer #2 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C | 3560.7 | Semi standard non polar | 33892256 | | Moupinamide,1TBDMS,isomer #3 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O | 3494.3 | Semi standard non polar | 33892256 | | Moupinamide,2TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)NCCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)=CC=C1O[Si](C)(C)C(C)(C)C | 3839.5 | Semi standard non polar | 33892256 | | Moupinamide,2TBDMS,isomer #2 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O | 3684.1 | Semi standard non polar | 33892256 | | Moupinamide,2TBDMS,isomer #3 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3726.3 | Semi standard non polar | 33892256 | | Moupinamide,3TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3948.7 | Semi standard non polar | 33892256 | | Moupinamide,3TBDMS,isomer #1 | COC1=CC(/C=C/C(=O)N(CCC2=CC=C(O[Si](C)(C)C(C)(C)C)C=C2)[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 3534.5 | Standard non polar | 33892256 |
|
|---|
| General References | - Turner CE, Elsohly MA, Boeren EG: Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980 Mar-Apr;43(2):169-234. doi: 10.1021/np50008a001. [PubMed:6991645 ]
- Song Y, Mei T, Liu Y, Kong S, Zhang J, Xie M, Ou S, Liang M, Wang Q: Metabolites Identification of Chemical Constituents From the Eggplant (Solanum melongena L.) Calyx in Rats by UPLC/ESI/qTOF-MS Analysis and Their Cytotoxic Activities. Front Pharmacol. 2021 Jul 15;12:655008. doi: 10.3389/fphar.2021.655008. eCollection 2021. [PubMed:34335243 ]
- Park JB: Isolation and characterization of N-feruloyltyramine as the P-selectin expression suppressor from garlic (Allium sativum). J Agric Food Chem. 2009 Oct 14;57(19):8868-72. doi: 10.1021/jf9018382. [PubMed:19807156 ]
- Veeriah V, Lee SH, Levine F: Long-term oral administration of an HNF4alpha agonist prevents weight gain and hepatic steatosis by promoting increased mitochondrial mass and function. Cell Death Dis. 2022 Jan 27;13(1):89. doi: 10.1038/s41419-022-04521-5. [PubMed:35087037 ]
- Lee SH, Veeriah V, Levine F: Liver fat storage is controlled by HNF4alpha through induction of lipophagy and is reversed by a potent HNF4alpha agonist. Cell Death Dis. 2021 Jun 11;12(6):603. doi: 10.1038/s41419-021-03862-x. [PubMed:34117215 ]
- (). Yannai, Shmuel. (2004) Dictionary of food compounds with CD-ROM: Additives, flavors, and ingredients. Boca Raton: Chapman & Hall/CRC.. .
|
|---|